Using An In Vitro Tissue Perfusion System to Detect the Functional Activities of Isolated Intestinal Tubes in Real Time
July 26th, 2024
We present a method for isolating rat intestinal tubes and assessing the impact of drugs on their tension, frequency, and amplitude in vitro. This method offers a valuable approach for researchers investigating intestinal tubes.
We present a method for isolating intestinal tubes and assessing the impact of drug on their tension, frequency, and amplitude in which this method offers a valuable approach for researchers in investigating intestinal tubes. The current experimental challenge is maintaining the consistency and the stability of technical methods to ensure reliable and reproducible scientific research outcomes, particularly considering the sensitivity and reliability inherited in biological systems. This protocol offers advantages such as simplicity, economical feasibility, easy control of experimental conditions, minimal influencing factors, high reproducibility and accurate results.
To begin, prepare a physiological salt solution or PSS. Saturate the solution by bubbling with a mixed gas of 95%oxygen and 5%carbon dioxide. Maintain the pH values of the solution between 7.38 and 7.42 with two millimolar sodium hydroxide.
Pre-cool, one third of the PSS to four degrees Celsius. Then prewarm the remaining solution to 37 degrees Celsius for subsequent experiments. Now gather Petri dishes filled with four degrees Celsius, PSS, surgical tweezers, and scissors.
Quickly place the stomach and intestine tubes in a Petri dish filled with four degrees Celsius PSS saturated with 95%oxygen and 5%carbon dioxide. Locate the duodenum in the Polaris of the stomach. Using tweezers, delicately lift the adjacent tissue and carefully trim it away from the intestine's edge with scissors.
Divide the intestine into one to two centimeter segments. To begin, turn on the in vitro tissue perfusion system. Adjust the instrument's bath temperature to 37 degrees Celsius.
Then place the 37 degrees Celsius physiological salt solution or PSS into the bath. Prepare a 15 centimeter surgical suture and soak it in four degrees Celsius PSS saturated with 95%oxygen and 5%carbon dioxide. Secure one end of the intestinal canal with the suture and use a steel needle hook to secure the other end.
Next, install the intestinal tube. Mount the segment with the steel needle hook at the bottom of the bath, and attach the other end of the surgical line to the transducer. Turn on the gas switch to allow bubbles to emerge in the bath.
Now open the data acquisition software and click on Start to ensure the corresponding path signal is being recorded. Rotate the spiral axis of the bath counterclockwise to relax the intestinal tubes to their natural state. Click on setup zero, all inputs to ensure that the software sets the intestinal tube's initial tension to zero grams.
Then rotate the spiral axis of the bath clockwise to pull the tension value to one gram and stabilize it in the 37 degrees Celsius PSS for 30 minutes. Observe the rhythmic spontaneous contraction waves in the software as this indicates a sufficient response. Next, add the test drug to the bath to study its effect on intestinal tube function.
Afterward, stop the data acquisition software and perform data analysis using the software. To edit the data board and select the analysis parameters, click on Window data pad and choose the average tension for the channel. Select the contraction curve before administration and click Add to data pad.
Then select the contraction curve after administration and click Add to data pad. The average tension value before and after administration will appear on the data pad in turn. Then click on Window data pad to copy data to other statistical analysis software for further analysis.
Analyze other parameters such as average amplitude, average frequency, and integral area under the curve. Replace the average tension with the respective parameter. Afterward, select the curve, click on Edit copy lab chart data to copy the data to drawing software for visualization.
The study examined the effects of various agents on the tension of isolated intestinal tub rings. Acetylcholine significantly enhanced tension in these tubes. Conversely, atropine inhibited the tension caused by acetylcholine.
Similarly, barium chloride also enhanced tension. On the other hand, both epinephrine and nifedipine inhibited tension in the isolated intestinal tube rings.
Overview
This article presents a method for isolating rat intestinal tubes and assessing the impact of drugs on their tension, frequency, and amplitude in vitro. The protocol aims to provide a reliable approach for researchers studying intestinal tubes.
Key Study Components
Area of Science
- Neuroscience
- Pharmacology
- Biological Systems
Background
- Maintaining consistency and stability in experimental methods is crucial.
- Biological systems are sensitive and require reliable techniques.
- High reproducibility and accurate results are essential for scientific research.
- This method addresses these challenges effectively.
Purpose of Study
- To isolate intestinal tubes for in vitro studies.
- To evaluate the effects of drugs on intestinal tube properties.
- To enhance the reliability of experimental outcomes.
Methods Used
- Preparation of a physiological salt solution (PSS).
- Saturation of the solution with a gas mixture of 95% oxygen and 5% carbon dioxide.
- Maintaining pH levels between 7.38 and 7.42 using sodium hydroxide.
- Assessing tension, frequency, and amplitude of intestinal tubes.
Main Results
- The method allows for controlled experimental conditions.
- Results demonstrate high reproducibility.
- Accurate measurement of drug effects on intestinal tubes.
- Offers a simple and economical approach for researchers.
Conclusions
- This protocol is valuable for studying intestinal tubes.
- It provides a reliable method for assessing drug impacts.
- Enhances the quality of research in biological systems.
Frequently Asked Questions
Executive Industry Relevance
Standardized in vitro intestinal tube perfusion enables real-time, quantitative assessment of gastrointestinal motor function under controlled conditions. This approach supports predictive evaluation of drug effects on intestinal motility, directly informing early-stage target validation and mechanistic de-risking in gastrointestinal drug discovery. High reproducibility and authentic functional readouts position this method as a critical asset for pipeline triage and cross-program comparability.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of drug-induced changes in intestinal contractility and motor patterns.
- Supports mechanistic de-risking by isolating functional responses to specific pharmacological agents.
- Provides quantitative data for functional target validation in gastrointestinal research.
- Facilitates portfolio triage by distinguishing compounds with desired motility profiles.
Screening & Assay Development
- Delivers validated, reproducible biological systems for compound screening in motility modulation.
- Standardizes assay conditions to ensure reliable, quantitative outputs such as tension, amplitude, and frequency.
- Enables scalable, platform-ready workflows for comparative evaluation of drug candidates.
- Supports robust assay development for downstream pharmacological profiling.
Translational & Preclinical Research
- Aligns in vitro functional outputs with disease-relevant gastrointestinal endpoints.
- Provides continuity from early discovery through preclinical validation of motility-modulating agents.
- Reduces translational risk by generating authentic, physiologically relevant data.
- Supports biomarker alignment for gastrointestinal functional studies when appropriate.
Pipeline & Workflow Integration
This perfusion-based assay integrates into the discovery-to-preclinical continuum, bridging early mechanistic studies and preclinical candidate selection for gastrointestinal therapeutics.
- Discovery Biology: Enables hypothesis testing of drug effects on intestinal contractility and pathway modulation.
- Screening: Provides reproducible, quantitative readouts for compound prioritization in motility assays.
- Analytics: Supports statistical comparison of pre- and post-intervention contractile parameters.
- Translational Research: Facilitates risk-adjusted advancement by aligning in vitro findings with in vivo motility endpoints.
- Enterprise Reuse: Offers a standardized, reusable platform for functional gastrointestinal studies across programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and reduces mechanistic ambiguity in motility research.
- Operational Value: Enhances reproducibility, standardization, and scalability of functional assays.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by providing authentic functional data early in the pipeline.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of gastrointestinal drug candidates.
Implementation Considerations
- Requires expertise in tissue isolation, perfusion system operation, and functional data analysis.
- Demands access to specialized instrumentation for real-time tension and contractility measurement.
- Necessitates rigorous cross-team standardization of assay setup and data acquisition protocols.
- May require adaptation for different species or intestinal segments based on research focus.
- Biological variability and tissue viability must be carefully managed to ensure data integrity.
